ScreenerHero

FLUIFluicell AB

STO · SE · Healthcare · Biotechnology · fluicell.com
32.90SEK+4.78%Mkt Cap: 4.32M $P/E: 0.05

Fluicell AB (publ), a life science company, develops and provides clay instruments for 3D bioprinting and cell analysis and flow control on single-cell level in Sweden. The company offers BIOPEN, a powerful tool for high…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap4.32M $
Enterprise Value4.20M $
Revenue (TTM)1.93M $
Gross Profit1.26M $
Net Income (TTM)-796.97K $
Revenue/Share1.403 USD
Last Price32.90 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees11
CountrySE
SectorHealthcare
IndustryBiotechnology
ISINSE0010831321
Valuation
P/E (Trailing)0.05
P/E (Forward)—
PEG—
EV/EBITDA-20.85
EV/Revenue2.18
P/S2.24
P/B3.18
EPS (TTM)678.85
EPS (Forward)—
52W Range
7.65042% of range67.20
52W High67.20 SEK
52W Low7.650 SEK
Profitability
Gross Margin218.79%
Oper. Margin43.41%
EBITDA Margin-10.45%
Profit Margin-138.82%
ROE-76.43%
ROA-45.10%
Growth
Revenue Growth186.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-472.90K $
CapEx (TTM)829.11K $
FCF Margin-48.99%
FCF Yield-21.85%
Net Debt-124.06K $
Net Debt/EBITDA0.62
Balance Sheet
Debt/Equity—
Current Ratio1.33
Quick Ratio0.72
Book Value/Sh10.35 SEK
Cash/Share0.9440 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:350
Split DateMar 26, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.37M
Float1.23M
Insiders18.77%
Institutions9.45%
Technical
SMA 5031.86 (+3.3%)
SMA 20020.10 (+63.7%)
Beta2.02
S&P 52W Chg19.18%
Avg Vol (30d)3.15K
Avg Vol (10d)3.86K
Technical Indicators
RSI (14)55.8
MACD-0.5517
MACD Signal-0.8833
MACD Hist.+0.3316
BB Upper32.58 SEK
BB Middle30.61 SEK
BB Lower28.64 SEK
BB Width12.90%
ATR (14)2.387 SEK
Vol Ratio (20d)1.70x